Zyagnum AG is an innovative technology company with vision and global demand.

Our claim

With the uniqueness and limitless possibilities of the EDIM process developed by us, it is our incentive as well as our obligation to carry on research on this path and to develop diagnostics with competent partners, which allows all patients a targeted therapy at an early stage.

Our company history

Our company history simply and clearly summarized for you.

1995

Discovery of TKTL1

Dr. Johannes Coy Discovers new universal biomarker at the German Institute for Cancer Research

2007

Foundation of Zyagnum AG

Zyagnum is founded to develop a technology platform and diagnostic test for cancer

2010

First in-house test

The first cancer-in-house test based on TKTL1 is launched in Germany - testing accuracy is not reliable and high enough for a commercial screening test

2017

Development completed

Zyagnum finishes development of the unique EDIM technology and achieves registration of the PanTum Detect cancer screening test

2018

PanTum Detect

Global market launch & development of additional tests.